35+ years in pharma and biotech. Co-founder of Akston Bioscience; former VP BD at SmartCells (sold to Merck for $500M+). Former Chief Business Officer at Elixir Pharmaceuticals; SVP at Cubist (acquired by Merck) and Nycomed Amersham (acquired by GE).
